Ali Madani worked as the director of machine learning at Cyclica Inc leading AI technology development front of Cyclica for drug discovery before acquisition of Cyclica by Recursion Pharmaceuticals. Ali completed his PhD at University of Toronto focusing on machine learning modeling in cancer setting and attained a Master of Mathematics from the University of Waterloo. As a believer in industry-oriented education and pro-democratization of knowledge, Ali has actively educated students and professionals through international workshops and courses on basic and advanced high-quality machine learning modeling. When not immersed in machine learning modeling and teaching, Ali enjoys exercising, cooking and traveling with his partner.
więcej »
